{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:52:01Z","timestamp":1787064721614,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T00:00:00Z","timestamp":1242604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T00:00:00Z","timestamp":1242604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/bmt.2009.107","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T10:20:19Z","timestamp":1242642019000},"page":"117-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma"],"prefix":"10.1038","volume":"45","author":[{"given":"H","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Reece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,18]]},"reference":[{"key":"BFbmt2009107_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","volume":"82","author":"JR Sawyer","year":"1995","unstructured":"Sawyer JR, Waldron JA, Jagannath S, Barlogie B . Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 1995; 82: 41\u201349.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFbmt2009107_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.leu.2402797","volume":"17","author":"CS Debes-Marun","year":"2003","unstructured":"Debes-Marun CS, Deqald GW, Bryant S, Picken E, Santana-Davila R, Gonzalez-Paz N et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia 2003; 17: 427\u2013436.","journal-title":"Leukemia"},{"key":"BFbmt2009107_CR3","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V91.8.3007.3007_3007_3010","volume":"91","author":"JC Cigudosa","year":"1998","unstructured":"Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michalli J, Jhanwar SC et al. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood 1998; 91: 3007\u20133010.","journal-title":"Blood"},{"key":"BFbmt2009107_CR4","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1182\/blood-2006-02-005496","volume":"108","author":"BA Walker","year":"2006","unstructured":"Walker BA, Leone PE, Jenner MW, Li C, Gonzalez D, Johnson DC et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood 2006; 108: 1733\u20131734.","journal-title":"Blood"},{"key":"BFbmt2009107_CR5","first-page":"953","volume":"26","author":"Y Marzin","year":"2006","unstructured":"Marzin Y, Jamet D, Douet-Guilbert N, Morel F, Le Bris M, Morice P et al. Chromosome 1 abnormalities in multiple myeloma. Anticancer Res 2006; 26: 953\u2013960.","journal-title":"Anticancer Res"},{"key":"BFbmt2009107_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2141.2007.06750.x","volume":"139","author":"H Chang","year":"2007","unstructured":"Chang H, Qi C, Xu W, Patterson B . 1p21 deletion is a novel poor prognostic factor in multiple myeloma. Br J Haematol 2007; 139: 51\u201354.","journal-title":"Br J Haematol"},{"key":"BFbmt2009107_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/sj.bmt.1705131","volume":"36","author":"H Chang","year":"2005","unstructured":"Chang H, Samiee S, Qi WY, Yi QL, Mikhael J, Chen CI et al. Genetic risk identifies myeloma patients who do not benefit from autologous stem cell transplantation. Bone Marrow Transplant 2005; 36: 793\u2013796.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009107_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-2141.2006.06237.x","volume":"134","author":"H Chang","year":"2006","unstructured":"Chang H, Yeung J, Xu W, Ning Y, Patterson B . A significant increase of CKS1B amplification from MGUS to multiple myeloma and plasma cell leukemia as demonstrated by interphase fluorescence in situ hybridization. Br J Haematol 2006; 134: 613\u2013615.","journal-title":"Br J Haematol"},{"key":"BFbmt2009107_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","volume":"64","author":"R Fonseca","year":"2004","unstructured":"Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546\u20131548.","journal-title":"Cancer Res"},{"key":"BFbmt2009107_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2141.2006.06481.x","volume":"136","author":"KL Wu","year":"2007","unstructured":"Wu KL, Beverloo B, Lokhorst HM, Segeren CM, van der Holt B, Steijaert MM et al. Abnormalities of chromosome 1p\/q are highly associated with 13\/13qdletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma. Br J Haematol 2007; 136: 615\u2013623.","journal-title":"Br J Haematol"},{"key":"BFbmt2009107_CR11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbmt.2007.05.014","volume":"13","author":"MH Qazilbash","year":"2007","unstructured":"Qazilbash MH, Saliba RM, Ahmed B, Parikh G, Mendoza F, Ashraf N et al. Deletion of short arm of chromosome 1 (del1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant. Biol Blood Marrow Transplant 2007; 13: 1066\u20131072.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009107_CR12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1182\/blood-2006-03-009910","volume":"108","author":"I Hanamura","year":"2006","unstructured":"Hanamura I, Stewart JP, Huang Y, Zhan F, Santra M, Sawyer JR et al. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood 2006; 108: 1724\u20131732.","journal-title":"Blood"},{"key":"BFbmt2009107_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2141.2006.06325.x","volume":"135","author":"H Chang","year":"2006","unstructured":"Chang H, Qi XY, Trieu Y, Xu W, Reeder RC, Ning Y et al. Multiple myeloma patients with CKS1B amplification have a poor progression free survival post-autologous stem cell transplantation. Br J Haematol 2006; 135: 486\u2013491.","journal-title":"Br J Haematol"},{"key":"BFbmt2009107_CR14","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/sj.leu.2404403","volume":"20","author":"R Fonseca","year":"2006","unstructured":"Fonseca R, Van Wier SA, Chng WJ, Ketterling R, Lacy MQ, Dispenzieri A et al. Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma. Leukemia 2006; 20: 2034\u20132040.","journal-title":"Leukemia"},{"key":"BFbmt2009107_CR15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","volume":"100","author":"R Fonseca","year":"2002","unstructured":"Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 2002; 100: 1417\u20131424.","journal-title":"Blood"},{"key":"BFbmt2009107_CR16","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/sj.leu.2403518","volume":"18","author":"H Kaufmann","year":"2004","unstructured":"Kaufmann H, Ackermann J, Baldia C, Nosslinger T, Wieser R, Seidl S et al. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma. Leukemia 2004; 18: 1879\u20131882.","journal-title":"Leukemia"},{"key":"BFbmt2009107_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood-2004-03-0833","volume":"105","author":"T Rasnussen","year":"2005","unstructured":"Rasnussen T, Kuehl M, Lodahl M, Johnsen HE, Dahl IM . Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood 2005; 105: 317\u2013323.","journal-title":"Blood"},{"key":"BFbmt2009107_CR18","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"15","author":"JD Shaughnessy","year":"2007","unstructured":"Shaughnessy JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 2007; 15: 2276\u20132284.","journal-title":"Blood"},{"key":"BFbmt2009107_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/geno.1999.5863","volume":"59","author":"AK Wong","year":"1999","unstructured":"Wong AK, Chen Y, Lian L, Ha PC, Petersen K, Laity K et al. Genomic structure, chromosomal location, and mutation analysis of the human CDC14A gene. Genomics 1999; 59: 248\u2013251.","journal-title":"Genomics"},{"key":"BFbmt2009107_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ncb777","volume":"4","author":"N Mailand","year":"2002","unstructured":"Mailand N, Lukas C, Kaiser BK, Jackson PK, Bartek J, Lukas J . Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat Cell Biol 2002; 4: 317\u2013322.","journal-title":"Nat Cell Biol"},{"key":"BFbmt2009107_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1476-4598-5-25","volume":"5","author":"MT Paulsen","year":"2006","unstructured":"Paulsen MT, Starks AM, Derheimer FA, Hanasoge S, Li L, Dixon JE et al. The p53-targeting human phosphatase hCdc14A interacts with the CdkI\/cyclin B complex and is differentially expressed in human cancers. Mol Cancer Res 2006; 5: 25.","journal-title":"Mol Cancer Res"}],"updated-by":[{"DOI":"10.1038\/bmt.2009.158","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T00:00:00Z","timestamp":1263340800000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009107","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T08:23:44Z","timestamp":1648023824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,18]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFbmt2009107"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.107","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,18]]},"assertion":[{"value":"12 February 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}